Sino-Argi Leading Biosciences (SHG:603970) — Market Cap & Net Worth
Market Cap & Net Worth: Sino-Argi Leading Biosciences (603970)
Sino-Argi Leading Biosciences (SHG:603970) has a market capitalization of $417.33 Million (CN¥2.85 Billion) as of August 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #13330 globally and #3982 in its home market, demonstrating a 1.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sino-Argi Leading Biosciences's stock price CN¥10.61 by its total outstanding shares 268800134 (268.80 Million). See 603970 net asset quality score to understand what proportion of total assets are financed by equity.
Sino-Argi Leading Biosciences Market Cap History: 2017 to 2026
Sino-Argi Leading Biosciences's market capitalization history from 2017 to 2026. Data shows growth from $642.52 Million to $417.33 Million (3.15% CAGR). Also see 603970 current and non-current assets for a full breakdown of the balance sheet.
Sino-Argi Leading Biosciences Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sino-Argi Leading Biosciences's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Sino-Argi Leading Biosciences stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.04x
Sino-Argi Leading Biosciences's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.93x
Sino-Argi Leading Biosciences's market cap is 2.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $642.52 Million | $3.50 Billion | $90.33 Million | 0.18x | 7.11x |
| 2018 | $332.26 Million | $3.73 Billion | $115.46 Million | 0.09x | 2.88x |
| 2019 | $337.65 Million | $4.34 Billion | $118.88 Million | 0.08x | 2.84x |
| 2020 | $562.16 Million | $6.64 Billion | $132.44 Million | 0.08x | 4.24x |
| 2021 | $704.19 Million | $8.82 Billion | $170.31 Million | 0.08x | 4.13x |
| 2022 | $800.59 Million | $11.70 Billion | $210.32 Million | 0.07x | 3.81x |
| 2023 | $604.17 Million | $10.46 Billion | $224.84 Million | 0.06x | 2.69x |
| 2024 | $558.54 Million | $10.60 Billion | $203.38 Million | 0.05x | 2.75x |
| 2025 | $505.83 Million | $11.24 Billion | $172.53 Million | 0.04x | 2.93x |
Competitor Companies of 603970 by Market Capitalization
Companies near Sino-Argi Leading Biosciences in the global market cap rankings as of August 18, 2026. Also see 603970 cash flow metrics for how efficiently the company converts equity into cash flow.
Key companies related to Sino-Argi Leading Biosciences by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #543 globally with a market cap of $50.57 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #842 globally with a market cap of $32.70 Billion USD ( CA$45.21 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1225 globally with a market cap of $21.71 Billion USD ( CN¥148.38 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1523 globally with a market cap of $16.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #543 | Corteva Inc | NYSE:CTVA | $50.57 Billion | $76.01 |
| #842 | Nutrien Ltd | TO:NTR | $32.70 Billion | CA$94.74 |
| #1225 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $21.71 Billion | CN¥28.04 |
| #1523 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $117.78 |
Sino-Argi Leading Biosciences Historical Marketcap From 2017 to 2026
Between 2017 and today, Sino-Argi Leading Biosciences's market cap moved from $642.52 Million to $ 417.33 Million, with a yearly change of 3.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥417.33 Million | -17.50% |
| 2025 | CN¥505.83 Million | -9.44% |
| 2024 | CN¥558.54 Million | -7.55% |
| 2023 | CN¥604.17 Million | -24.53% |
| 2022 | CN¥800.59 Million | +13.69% |
| 2021 | CN¥704.19 Million | +25.27% |
| 2020 | CN¥562.16 Million | +66.49% |
| 2019 | CN¥337.65 Million | +1.62% |
| 2018 | CN¥332.26 Million | -48.29% |
| 2017 | CN¥642.52 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 18th, 2026 the market cap of Sino-Argi Leading Biosciences was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $417.33 Million USD |
| MoneyControl | $417.33 Million USD |
| MarketWatch | $417.33 Million USD |
| marketcap.company | $417.33 Million USD |
| Reuters | $417.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more